BM547,and in Streptomyces sp. 1061>2). The strain used in our experiments, NRRL3482, is known to produce predominantly tuberactinomycin A (2), as well as low levels of tuberactinomycins B (viomycin) (3), N (4), and O (5)3~5). The structures of these compounds are shown in Figure 1 . In general, tuberactinamine A differs from the tuberactinomycins in that it lacks a /Mysine side chain.
Based upon this structural difference, we hypothesized that fermenting NRRL3482 in the presence of (S>2-aminoethyl-L-cysteine (AEC) would result in the production of tuberactinamine A. AECis known to be a potent inhibitor of lysine-2,3-aminomutase, the enzyme responsible for converting L-lysine to L-/?-lysine6). In addition, radiolabeling studies done by Carter et al. have shown that the L-/?-lysine side chain of viomycin is derived from L-lysine7). Therefore, we reasoned that if the y-hydroxy-/?-lysine side chain of tuberactinomycin A was derived from L-/Mysine, then the addition of AEC would inhibit its formation and tuberactinamine A would accumulate as the final product. This hypothesis was demonstrated experimentally.
To test the effect of AECaddition on the production profile of S. griseoverticillatus var. tuberadieus NRRL 3482, this strain was patched onto YPDagar (1% Difco yeast extract, 1% Difco Bacto peptone, 0.5% dextrose, 1% MOPS, and 1.7% Difco Bacto agar, pH 7.0) from a spore stock stored in 20% glycerol at -20°C. The patch was grown at 28°C for 5 days. After 5 days, a 6mmdiameter plug of the patch was inoculated into 30ml seed medium (2% soybean meal, 1%corn meal, 2% corn steep liquor, 0.6% NaNO3, and 0.02% KH2PO4, pH 7.7) in 300ml Erlenmeyer flasks and incubated at 29°C, 200rpm, 48 hours. After 48 hours, the contents of the seed flasks were pooled and 2.5ml of the pooled cultures were inoculated into 25 ml production medium (3% nutrisoy flour, 3% corn starch, 1.5% NaCl, and 2% dextrose, pH 7.0) in 250ml Erlenmeyer flasks. AECwas made up to lOO g/liter, filter-sterilized through a 0.2/mi filter, and added either before inoculation of the production stage or at 24 hours into production. The cultures were incubated at 29°C, 200rpm, for a total of 4days.
In order to determine whether added AEChad shifted the production profile of the organism from compound 2 to 1, the samples were harvested and assayed by HPLC.
To harvest, the fermentation broth was clarified by centrifugation, and 0.5ml of the clarified broth was added to 9.5ml of the mobile phase composed of 50mM HPLCassay, the chromatograms of AEOsupplemented cultures were compared to the un-supplemented controls. From these results, it was evident that the addition of AEC altered the production profile of the organism.
Without added AEC, 2 was the predominant product. When AECwas added at 2g/liter immediately before inoculation, 2 was only made at low levels and a novel component thought to be compound1 was observed.
To confirm that the new product was indeed 1, the compoundwas isolated using a two-stage purification that consisted of ion exchange chromatography and preparative HPLC.The fermentation broth was clarified by a combination of filtration and centrifugation. The clarified broth was then loaded onto IRC-76 in a mixture of the Na+ and H+ form. After washing the column with H2Oand 0.3n acetic acid, compound 1 was eluted with 0.1N H2SO4. The eluent was subsequently neutralized with IRA-93 resin in the basic form and desalted twice by precipitating in an excess of methanol and filtering. The desalted product was concentrated to approximately 100 ml using a rotary evaporator followed by drying to completion in a vacuumoven. The product was purified further using preparative HPLCon a Waters Millennium System. Samples were monitored at 270 nm using a Waters 996 diode array detector. For recovery 
